ESPL1 and lymphoma: ESPL1+/hyp, p53−/− mice developed aggressive and widespread lymphomas involving the lung, liver, thymus, bone marrow and peripheral blood, with a significantly reduced latency compared to p53−/− animals alone (Figure 2, red vs. blue line, P<0.005, Log Rank Test).